Interictal Burden of Cluster Headache Greatly Affects Disease Burden and Quality of Life
Survey findings suggest that cluster headache attacks can negatively affect an individual’s career, education, and social life.
Migraine and Headache
ACHIEVE II Trial Finds Ubrogepant Superior to Placebo for Pain Freedom in Moderate, Severe Migraine
Acute treatment of migraine with ubrogepant, an oral calcitonin gene-related peptide antagonist, was superior to placebo for migraine pain freedom.
Migraine Aura Complexity Score Stratifies and Identifies Phenotypes of Migraine With Aura
The newly developed Migraine Aura Complexity Score is effective for stratifying patients with migraine with aura.
New Findings on Timing of Migraines After Poor Sleep
Researchers found that a poor night’s sleep may increase risk for migraine the following day, rather than the next morning.
Ubrogepant Approved for Acute Treatment of Migraine
The Food and Drug Administration (FDA) has approved Ubrelvy (ubrogepant tablets; Allergan), the first oral calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of migraine with or without aura in adults.
Evidence Supports Use of High-Dose Aspirin for Migraine
Evidence supports the use of high-dose aspirin for treating acute migraine and low-dose aspirin for prevention of recurrent attacks.
Comorbidity-Based Migraine Subgroups Predict Progression of Episodic to Chronic Migraine
Various migraine subgroups based on comorbidities can predict the risk for the progression of episodic migraine to chronic migraine.
Onabotulinum May Decrease Opioid Use, Reduce Severity and Frequency of Nonmigraine Headache
In patients with chronic nonmigraine headaches, onabotulinum toxin type A injections may reduce pain severity and frequency of headaches.
Neurosurgery for Craniofacial Pain Syndromes: Update and Expert Interview
Many patients with craniofacial pain syndromes such as trigeminal neuralgia, cluster headache, and migraine have an adequate response to pharmacologic therapies.
The Association Between Different Subtypes of Major Depressive Disorder and Migraine
Researchers found evidence for a divergent association between lifetime MDD and the prevalence and severity of symptoms in patients with migraine.
Next post in Migraine and Headache
